Michel Komajda

9.3k total citations · 2 hit papers
25 papers, 3.5k citations indexed

About

Michel Komajda is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Michel Komajda has authored 25 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Michel Komajda's work include Heart Failure Treatment and Management (5 papers), Mitochondrial Function and Pathology (3 papers) and Genetic Neurodegenerative Diseases (3 papers). Michel Komajda is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Mitochondrial Function and Pathology (3 papers) and Genetic Neurodegenerative Diseases (3 papers). Michel Komajda collaborates with scholars based in France, United Kingdom and Italy. Michel Komajda's co-authors include David D. Waters, Mark J. Caulfield, Charles L. Shear, Bryan Brewer, Marian R. Fisher, Lori Mosca, Mats Eriksson, James H. Revkin, John J.P. Kastelein and Philip J. Barter and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Applied Physiology.

In The Last Decade

Michel Komajda

23 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Torcetrapib in Patients at High Risk for Coronary Events

2007 2.2k citations Philip J. Barter, Mark J. Caulfield et al. New England Journal of Medicine profile →
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

2007 561 citations Philip Home, Stuart Pocock et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Komajda France	13	1.7k	1.7k	1.0k	830	459	25	3.5k
Mieke D. Trip Netherlands	33	1.0k 0.6×	1.8k 1.0×	1.2k 1.1×	723 0.9×	578 1.3×	70	3.6k
John A. Farmer United States	31	882 0.5×	2.2k 1.3×	1.1k 1.1×	467 0.6×	523 1.1×	105	3.8k
Esteban Linares United States	5	1.6k 0.9×	2.0k 1.2×	1.8k 1.7×	501 0.6×	433 0.9×	6	3.9k
Junji Koizumi Japan	27	1.4k 0.8×	2.5k 1.5×	684 0.7×	903 1.1×	808 1.8×	83	3.7k
M.J. Whiting Australia	20	1.7k 1.0×	1.6k 0.9×	733 0.7×	948 1.1×	329 0.7×	39	3.7k
Markus Abt Switzerland	19	1.1k 0.7×	1.5k 0.9×	669 0.6×	376 0.5×	458 1.0×	49	3.0k
G. Kees Hovingh Netherlands	30	1.3k 0.7×	2.1k 1.3×	1.0k 1.0×	394 0.5×	646 1.4×	76	3.4k
Claude Gagné Canada	34	1.9k 1.1×	2.6k 1.6×	1.1k 1.1×	463 0.6×	858 1.9×	77	4.0k
Ulrich Julius Germany	28	1.5k 0.9×	1.5k 0.9×	735 0.7×	548 0.7×	257 0.6×	173	3.6k
Benjamin J. Ansell United States	22	1.6k 1.0×	1.9k 1.1×	711 0.7×	613 0.7×	560 1.2×	33	3.9k

Countries citing papers authored by Michel Komajda

Since Specialization

Citations

This map shows the geographic impact of Michel Komajda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Komajda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Komajda more than expected).

Fields of papers citing papers by Michel Komajda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Komajda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Komajda. The network helps show where Michel Komajda may publish in the future.

Co-authorship network of co-authors of Michel Komajda

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Komajda. A scholar is included among the top collaborators of Michel Komajda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Komajda. Michel Komajda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruandet, Amélie, et al.. (2025). Prediction of 90 Day Mortality in Elderly Patients with Acute HF from e-Health Records Using Artificial Intelligence. ESC Heart Failure. 12(3). 2200–2209. 2 indexed citations

Lafuente‐Lafuente, Carmelo, Olivier Hanon, Éric Pautas, et al.. (2016). 0481: Clinical profile of patients hospitalized for acute heart failure in cardiology and in geriatrics. A survey in greater Paris University hospitals. Archives of Cardiovascular Diseases Supplements. 8(1). 31–31. 1 indexed citations

Simpson, Joanne, Davide Castagno, Robert N. Doughty, et al.. (2015). Is Heart Rate a Risk Marker in Patients with Chronic Heart Failure and Concomitant Atrial Fibrillation? Results from the MAGGIC Meta-Analysis. European Journal of Heart Failure. 17(11). 1182–1191. 46 indexed citations

Pousset, Françoise, L. Legrand, Marie‐Lorraine Monin, et al.. (2015). A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia. JAMA Neurology. 72(11). 1334–1334. 71 indexed citations

Ruşinaru, Dan, Christophe Tribouilloy, Colin Berry, et al.. (2012). Relationship of Serum Sodium Concentration to Mortality in a Wide Spectrum of Heart Failure Patients with Preserved and with Reduced Ejection Fraction: An Individual Patient Data Meta-Analysis. European Journal of Heart Failure. 14(10). 1139–1146. 95 indexed citations

McAlister, Finlay A., Justin A. Ezekowitz, Luigi Tarantini, et al.. (2012). Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction. Circulation Heart Failure. 5(3). 309–314. 152 indexed citations

Friedrich, Felix W., Pedro Bausero, Yi Sun, et al.. (2009). A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. European Heart Journal. 30(13). 1648–1655. 32 indexed citations

Komajda, Michel, Paula Curtis, M Hanefeld, et al.. (2008). Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovascular Diabetology. 7(1). 10–10. 34 indexed citations

Home, Philip, Stuart Pocock, Henning Beck‐Nielsen, et al.. (2007). Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis. New England Journal of Medicine. 357(1). 28–38. 561 indexed citations breakdown →

10.

Barter, Philip J., Mark J. Caulfield, Mats Eriksson, et al.. (2007). Effects of Torcetrapib in Patients at High Risk for Coronary Events. New England Journal of Medicine. 357(21). 2109–2122. 2218 indexed citations breakdown →

11.

Beck‐Nielsen, Henning, M Hanefeld, Michel Komajda, et al.. (2005). Randomized controlled trial of the effect of rosiglitazone in combination therapy on ambulatory blood pressure in people with type 2 diabetes mellitus followed for 12 months. 3 indexed citations

12.

Komajda, Michel. (2004). Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. Journal of Cardiac Failure. 10(1). S1–S4. 59 indexed citations

13.

Bouchier, Christiane, Gisèle Bonne, Laëtitia Duboscq-Bidot, et al.. (2003). 151 Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation. European Journal of Heart Failure Supplements. 2(1). 26–26. 6 indexed citations

14.

Pousset, Françoise, Richard Isnard, & Michel Komajda. (2002). [Prognostic value of neurohormones in heart failure in clinical practice].. PubMed. 95 Spec 4(5 Spec 4). 27–32. 1 indexed citations

15.

Isnard, Richard, Hanna Kalotka, Alexandra Dürr, et al.. (1997). Correlation Between Left Ventricular Hypertrophy and GAA Trinucleotide Repeat Length in Friedreich's Ataxia. Circulation. 95(9). 2247–2249. 66 indexed citations

16.

Morvan, Daniel, Michel Komajda, Alexis Brice, et al.. (1992). Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study. European Heart Journal. 13(10). 1393–1398. 32 indexed citations

17.

Lechat, P, et al.. (1992). [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency].. PubMed. 85(6). 863–70. 4 indexed citations

18.

Komajda, Michel, et al.. (1990). Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy. The American Journal of Cardiology. 65(17). H37–H42. 16 indexed citations

19.

Lascault, G, Michel Komajda, G Drobinski, & Y Grosgogeat. (1986). Left coronary artery aneurysm and anteroseptal acute myocardial infarction following blunt chest trauma. European Heart Journal. 7(6). 538–540. 10 indexed citations

20.

Komajda, Michel, Michel Eugène, Jordan Evans, Denise Lecossier, & Y Grosgogeat. (1981). [Long-term treatment of severe cardiac failure with captopril (author's transl)].. PubMed. 10(19). 1587–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact